News und Analysen
Medigene AG: Medigene and Cytovant enter into service agreement for DC vaccine manufacturing process development
Planegg/Martinsried (19.10.2020) - Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies for the
Evotec: Nach Abu Dhabi nun Bill Gates an Bord!
Evotec (WKN: 566480) meldet heute eindrucksvolle News mit Promifaktor. So wird Bill Gates – der Microsoft-Nerd, über den Elon Musk jüngst in Anspielung auf Michael Jacksons Hit "Billie Jean" sagte
EnWave Announces Normal Course Issuer Bid
Vancouver, B.C., October 19, 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave,” or the "Company” - https://www.commodity-tv.com/play/enwave-update-on-covid-19-impact-rev-machine-sales
EnWave kündigt Aktienrückkaufprogramm an
Vancouver, B.C., 19. Oktober 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave" oder das "Unternehmen" - https://www.commodity-tv.com/play/enwave-update-on-covid-19-impact-rev-machine
Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020
Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency, and transparency
Epigenomics: Aktie crasht -77% nach US-Schock
Die staatliche US-Krankenversicherung Centers for Medicare & Medicaid Services (CMS) lehnt Epi proColon ab. Das geht aus einem vorläufigen Erstattungsvorschlag hervor. Die Schockwellen sind in der E
Transgene: Acceptance of Late Breaking Abstract at Upcoming SITC 2020 Conference, on The Detailed Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-positive Cancers
Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that detailed results of the
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical
Quantum Genomics to receive up to $50 million in upfront and milestone payments plus double-digit royalties on sales
Qilu Pharmaceutical to receive an exclusive license to develop and commercialize
IMV Inc. Re-establishes At-the-Market Facility
IMV Inc. (TSX: IMV; NASDAQ: IMV) (the "Company" or “IMV”), a clinical-stage biopharmaceutical company, today announced that it has entered into an equity distribution agreement, dated October 16
Charles River Laboratories Adds George Llado to Board of Directors
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of George Llado, Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, Inc., to
Medigene AG: Drei Poster Präsentationen von Medigene auf dem SITC Annual Meeting
Planegg/Martinsried (15.10.2020) - Wissenschaftler der Medigene AG (Medigene, FWB: MDG1, Prime Standard), ein Immunonkologie-Unternehmen mit klinischen Projekten fokussiert auf die
Medigene AG: Three Medigene poster presentations at SITC Annual Meeting
Planegg/Martinsried (15.10.2020) - Scientists of Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical stage immuno-oncology company focusing on the development of T cell
Premier Inc. Contracts with HHS on Data-Driven Initiative to Improve U.S. Maternal Health
Premier Inc. (NASDAQ: PINC) today announced a new, two-year, $8 million national partnership with the U.S. Department of Health and Human Services (HHS) Office of Women’s Health to leverage
Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award
Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test category. The
NeutriSci Enters the Second Highest Grossing Market with New Distribution in the State of Washington
Vancouver, British Columbia – October 15, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company
NeutriSci betritt mit dem US-Bundesstaat Washington den Markt mit den zweithöchsten Cannabis-Umsätzen weltweit
Vancouver (British Columbia), 15. Oktober 2020 - NeutriSci International Inc. (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) („NeutriSci“ oder das „Unternehmen“, ein innovatives
Biomarkers Associated With Clinical Response in Patients With r/r DLBCL Treated With DPX-Survivac Combination Therapy to be Presented at the Upcoming SITC Annual Meeting
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announces that
BOIRON : Projected timetable of the next publications and events 2021
The projected timetable of the next publications and events for the year 2021 is the following one:
Publications Date of publication (after market closing) Information meetings
Transgene and BioInvent to Present Data on Oncolytic Virus BT-001 at the SITC 35th Anniversary Annual Meeting
Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB
Lysogene Provides Update on the AAVance Clinical Trial Evaluating LYS-SAF302 in Patients with MPS IIIA
Regulatory News:
Lysogene (Paris:LYS) (FR0013233475 – LYS), a Phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today announced that a patient has passed away
Sensorion Obtains €3 Million Loans, Including €2 Million Guaranteed by the French Government (PGE) and €1 Million as RDI Loan Through Bpifrance
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
Xencor to Present Data from the Phase 1 Study of XmAb®20717 and Three Research Programs at the SITC Annual Meeting
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced four poster
Hanger Announces Executive Appointments To Lead Its Patient Care and Products & Services Business Segments
Hanger, Inc. (NYSE: HNGR) today announced the promotion and hiring of two senior executives to lead its two business segments, effective Nov. 2, 2020:
-
Regina Weger has been promoted to
EOS imaging Reports 9-month Revenue up +32% Year-on-year
Regulatory News:
EOS imaging (Euronext, FR0011191766 - EOSI - PEA-PME eligible) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
Humana Announces Major Tennessee Expansion, Will Sell Medicare Advantage Plans in 31 More Counties
As part of Humana Inc.’s (NYSE: HUM) major Tennessee expansion in 2021, the leading health and well-being company announced today it is introducing a new Medicare Advantage Health Maintenance